JEUVEAU Trademark

Trademark Overview

On Thursday, May 25, 2017, a trademark application was filed for JEUVEAU with the United States Patent and Trademark Office. The USPTO has given the JEUVEAU trademark a serial number of 87464767. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by Evolus, Inc.. The JEUVEAU trademark is filed in the Pharmaceutical Products category with the following description:

Injectable botulinum toxin for medical use for use in aesthetic procedures, namely, for the treatment of wrinkles
jeuveau

General Information

Serial Number87464767
Word MarkJEUVEAU
Filing DateThursday, May 25, 2017
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5776155
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesInjectable botulinum toxin for medical use for use in aesthetic procedures, namely, for the treatment of wrinkles

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 1, 2017
Primary Code005
First Use Anywhere DateSaturday, March 30, 2019
First Use In Commerce DateSaturday, March 30, 2019

Trademark Owner History

Party NameEvolus, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameEvolus, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameEvolus, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events

Event DateEvent Description
Thursday, August 24, 2017NON-FINAL ACTION WRITTEN
Monday, May 29, 2017NEW APPLICATION ENTERED
Thursday, June 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 24, 2017ASSIGNED TO EXAMINER
Thursday, August 24, 2017NON-FINAL ACTION E-MAILED
Thursday, August 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 8, 2018ASSIGNED TO LIE
Saturday, March 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 26, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, March 26, 2018EXAMINERS AMENDMENT E-MAILED
Monday, March 26, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 26, 2018EXAMINER'S AMENDMENT ENTERED
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 9, 2018SOU TEAS EXTENSION RECEIVED
Friday, November 9, 2018SOU EXTENSION 1 FILED
Friday, November 9, 2018SOU EXTENSION 1 GRANTED
Tuesday, November 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 25, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 24, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, April 24, 2019USE AMENDMENT FILED
Tuesday, May 7, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 8, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 9, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 10, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

jeuveau namely treatment wrinkles procedures aesthetic botulinum toxin medical injectable